-
Pill for rare ageing disease on the horizonBy Dr Ananya Mandal, MD Scientists have found that a drug used in transplant patients could reverse the effects of premature ageing and extend human life by over 10 years. A team of US scientis2011/7/4
-
Multinational drug companies' scamIn an Al Jazeera opinion piece, the first in a two-part series, Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, examines how multinational drug companies control ma2011/7/1
-
Research raises questions about some generic epilepsy drugsGeneric anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may2011/7/1
-
SFDA held videoconference on implementing Provisions for Adverse Drug Reaction Reporting and MonitoringThe newly revised Provisions for Adverse Drug Reaction Reporting and Monitoring will come into effect on July 1, 2011. The State Food and Drug Administration (SFDA) held a videoconference for implemen2011/6/30
-
FDA looks at Avastin risksBy Dr Ananya Mandal, MD The US Food and Drug Administration is holding a two-day hearing that pits the FDA's Center for Drug Evaluation and Research against Genentech, that manufactures breast canc2011/6/30
-
Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debateLos Angeles Times: California's Grand Budget Bargain That Wasn't The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocke2011/6/30
-
Supreme Court rules in favor of ‘pharma’ data miningBy Ananya Mandal, MD The U.S. Supreme Court ruled that the pharmaceutical companies could use the information that they gained from doctors’ prescribing records. The data mining had been restricted2011/6/30
-
Drug labels sometimes lack key safety warnings: Consumer Reports HealthNo Federal Monitoring of Drug Labels; What Consumers Can Do to Stay Safe It's comparable to driving a car without a seatbelt—a new investigation from Consumer Reports Health finds that drug labels2011/6/29
-
Merck, UPS extend logistics and distribution agreementUPS (NYSE: UPS) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the companies have significantly broadened their existing distribution and logistics agree2011/6/29
-
Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for childrenA cellulose powder has been used increasingly for many years against allergic rhinitis. Still, there has been a shortage of scientific evidence for its efficacy in seasonal allergic rhinitis (hay feve2011/6/29